ADO Antikörper (C-Term)
Kurzübersicht für ADO Antikörper (C-Term) (ABIN950285)
Target
Alle ADO Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 206-233, C-Term
-
Spezifität
- This antibody reacts to ADO.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human and Mouse.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 206-233 amino acids from the C-terminal region of human ADO
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ADO (2-Aminoethanethiol (Cysteamine) Dioxygenase (ADO))
-
Andere Bezeichnung
- ADO
-
Hintergrund
- Human thiol dioxygenases include cysteine dioxygenase (CDO, MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO, EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine (Dominy et al., 2007).Synonyms: 2-aminoethanethiol dioxygenase, C10orf22, Cysteamine dioxygenase
-
Gen-ID
- 84890
-
NCBI Accession
- NP_116193
Target
-